Free Trial
NASDAQ:TYRA

Tyra Biosciences (TYRA) Stock Price, News & Analysis

Tyra Biosciences logo
$12.62 -0.27 (-2.06%)
As of 03:33 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Tyra Biosciences Stock (NASDAQ:TYRA)

Key Stats

Today's Range
$12.60
$13.16
50-Day Range
$9.10
$12.88
52-Week Range
$6.42
$29.60
Volume
196,214 shs
Average Volume
301,894 shs
Market Capitalization
$672.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.83
Consensus Rating
Buy

Company Overview

Tyra Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

TYRA MarketRank™: 

Tyra Biosciences scored higher than 44% of companies evaluated by MarketBeat, and ranked 652nd out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tyra Biosciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tyra Biosciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about Tyra Biosciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Tyra Biosciences are expected to decrease in the coming year, from ($1.57) to ($2.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tyra Biosciences is -7.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tyra Biosciences is -7.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tyra Biosciences has a P/B Ratio of 2.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Tyra Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    18.27% of the float of Tyra Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Tyra Biosciences has a short interest ratio ("days to cover") of 19.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Tyra Biosciences has recently decreased by 1.32%, indicating that investor sentiment is improving.
  • Dividend Yield

    Tyra Biosciences does not currently pay a dividend.

  • Dividend Growth

    Tyra Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    18.27% of the float of Tyra Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Tyra Biosciences has a short interest ratio ("days to cover") of 19.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Tyra Biosciences has recently decreased by 1.32%, indicating that investor sentiment is improving.
  • News Sentiment

    Tyra Biosciences has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Tyra Biosciences this week, compared to 4 articles on an average week.
  • Search Interest

    1 people have searched for TYRA on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tyra Biosciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $628,358.00 in company stock.

  • Percentage Held by Insiders

    15.20% of the stock of Tyra Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    84.14% of the stock of Tyra Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Tyra Biosciences' insider trading history.
Receive TYRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tyra Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TYRA Stock News Headlines

Tyra Biosciences' (TYRA) "Buy" Rating Reaffirmed at HC Wainwright
Brokerages Set Tyra Biosciences, Inc. (NASDAQ:TYRA) PT at $30.83
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
See More Headlines

TYRA Stock Analysis - Frequently Asked Questions

Tyra Biosciences' stock was trading at $13.90 at the start of the year. Since then, TYRA stock has decreased by 9.2% and is now trading at $12.6150.

Tyra Biosciences, Inc. (NASDAQ:TYRA) announced its quarterly earnings results on Thursday, August, 14th. The company reported ($0.47) EPS for the quarter, beating the consensus estimate of ($0.53) by $0.06.

Tyra Biosciences (TYRA) raised $100 million in an initial public offering on Wednesday, September 15th 2021. The company issued 6,700,000 shares at $14.00-$16.00 per share.

Top institutional shareholders of Tyra Biosciences include Canaan Partners XI LLC (6.80%), Commodore Capital LP (5.84%), Vestal Point Capital LP (5.00%) and Sio Capital Management LLC (1.53%). Insiders that own company stock include Todd Harris, Nina S Kjellson, Daniel Bensen, Mva Investors, Llc, Gilla Kaplan and Alan Fuhrman.
View institutional ownership trends
.

Shares of TYRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tyra Biosciences investors own include American Water Works (AWK), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC), Waste Connections (WCN), AU Optronics (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/14/2025
Today
8/28/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TYRA
CIK
1863127
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$33.00
Low Price Target
$28.00
Potential Upside/Downside
+139.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.78)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$86.48 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-31.22%
Return on Assets
-29.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
21.94
Quick Ratio
21.94

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.67 per share
Price / Book
2.27

Miscellaneous

Outstanding Shares
53,300,000
Free Float
45,196,000
Market Cap
$686.50 million
Optionable
Optionable
Beta
1.08

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:TYRA) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners